Scientific credibility is a key differentiator for early-stage life science ventures. This advisory service helps biotech and neurotech startups build rigorous, fundable research strategies grounded in the latest neuroscience. Drawing on deep domain knowledge and translational experience, we support teams to design robust studies, communicate effectively with stakeholders, and de-risk their programmes at pace.
This service is designed for founders, R&D leads, and investors building or evaluating scientific ventures in neurology and neuroscience. Typical clients include:
Biotech and therapeutics startups targeting neurodegenerative or CNS disorders
MedTech and digital health companies entering neuro markets with sensing, diagnostic or interventional technologies
Platform technology companies seeking to validate relevance in neurobiology applications
Early-stage funds or accelerators needing scientific diligence and advisory support
R&D Credibility Review: Review of your scientific rationale, supporting evidence, and biological targets. We assess the translatability of your models, the coherence of your hypotheses, and alignment with disease biology and unmet need.
Format: Document review + written summary + feedback session
Study Design & Strategy Input: Input on experimental design (e.g. in vitro/in vivo models, behavioural endpoints, biomarker strategies), timelines, and feasibility. Ensures your studies are well-positioned for both scientific and investor scrutiny.
Format: 1:1 advisory calls + follow-up notes
Scientific Positioning & Communication: Guidance on how to present your science in grant applications, pitch decks, and regulatory-facing materials. We ensure the narrative is technically sound and persuasive to reviewers, collaborators, and funders.
Format: Slide/pitch review + copy edits + strategic messaging session
On-Demand Expert Support: Flexible support model for ongoing advisory during preclinical and translational phases. Support can be provided in sprint-style engagements or monthly retainers.
Format: Bespoke; includes meetings, reviews, and background research as needed
A credible, well-structured scientific foundation for fundraising and partnerships
Improved confidence in study design, decision-making, and translational planning
Reduced risk of scientific gaps or missteps delaying progress
Stronger positioning in competitive markets and funding landscapes